citalopram has been researched along with s20098 in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (81.25) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Guilleminault, C; Hajak, G; Keufer-Le Gall, S; Laredo, J; Montplaisir, J; Philip, P; Quera-Salva, MA | 1 |
| Corruble, E; Demyttenaere, K; Hale, A; Kasper, S; Picarel-Blanchot, F; Quera-Salva, MA | 1 |
| De Berardis, D; Di Giannantonio, M; Fornaro, M; Marini, S; Martinotti, G; Moschetta, FS; Serroni, N; Valchera, A | 1 |
| Belaïdi, C; Corruble, E; de Bodinat, C; Goodwin, GM | 1 |
| Ahokas, A; Albarran, C; Avedisova, AS; Höschl, C; Jarema, M; Márquez, MS; Oh, KS; Olivier, V; Stein, DJ | 1 |
| Baldwin, DS; Elnazer, HY | 1 |
| Becker, T; Kösters, M; Staudigl, L | 1 |
| Brignone, M; Ereshefsky, L; Francois, C; Lançon, C; Llorca, PM; Rive, B; Salah, S | 1 |
| Domotor, E; Hermanne, EF | 1 |
| Deakin, JF; Gabriel, C; Gaillard, R; Goodwin, G; Gruget, C; Harmer, C; Jabourian, A; Klinge, C; MacFayden, C; Meyniel, F; Milligan, H; Montejo, AL; Mullings, E | 1 |
| de Bodinat, C; Dehelean, P; Nuss, P; Picarel-Blanchot, F; Raba, V; Udristoiu, T | 1 |
| Ahokas, A; Bauer, M; Bitter, I; de Bodinat, C; Hӧschl, C; Jarema, M; Khoo, JP; Matharan, S; Mosolov, SN; Olivier, V; Picarel-Blanchot, F; Stein, DJ; Van Ameringen, M; Vavrusova, L | 1 |
| Holper, L | 1 |
| Uvais, NA | 1 |
| Abdul Karim, M; Al-Baz, N; Alabdulla, M; Haddad, PM; Ouanes, S | 1 |
2 review(s) available for citalopram and s20098
| Article | Year |
|---|---|
[If the general practitioner has to decide: what is the evidence for the selection of antidepressants?].
Topics: Acetamides; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Evidence-Based Medicine; General Practice; Germany; Guideline Adherence; Humans; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies.
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Benzofurans; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Humans; Hypnotics and Sedatives; Indoles; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulfides; Thiophenes; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2014 |
6 trial(s) available for citalopram and s20098
| Article | Year |
|---|---|
Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients.
Topics: Acetamides; Adult; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Melatonin; Middle Aged; Polysomnography; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Treatment Outcome; Wakefulness | 2011 |
Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial.
Topics: Acetamides; Adult; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Double-Blind Method; Emotions; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Sleep; Surveys and Questionnaires; Time Factors; Treatment Outcome; Wakefulness | 2013 |
Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Citalopram; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult | 2014 |
Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale.
Topics: Acetamides; Adult; Citalopram; Double-Blind Method; Emotions; Female; Healthy Volunteers; Humans; Hypnotics and Sedatives; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Young Adult | 2015 |
Early effect on general interest, and short-term antidepressant efficacy and safety of agomelatine (25-50mg/day) and escitalopram (10-20mg/day) in outpatients with Major Depressive Disorder. A 12-week randomised double-blind comparative study.
Topics: Acetamides; Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Romania; Severity of Illness Index; Treatment Outcome | 2016 |
12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25-50 mg/day) versus escitalopram (10-20 mg/day) in out-patients with severe generalized anxiety disorder.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Citalopram; Female; Follow-Up Studies; Humans; Interview, Psychological; Male; Middle Aged; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Young Adult | 2018 |
8 other study(ies) available for citalopram and s20098
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline.
Topics: Acetamides; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder; Depressive Disorder, Major; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome; Young Adult | 2013 |
Agomelatine reversal of escitalopram-induced apathy: a case report.
Topics: Acetamides; Aged; Apathy; Citalopram; Depressive Disorder, Major; Humans; Hypnotics and Sedatives; Male; Motivation; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors | 2013 |
Treatment with citalopram, but not with agomelatine, adversely affects sperm parameters: a case report and translational review.
Topics: Acetamides; Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalopram; Depression; Humans; Male; Selective Serotonin Reuptake Inhibitors; Semen Analysis; Spermatozoa | 2014 |
[The temporal accuracy of agomelatine administration and comparison of antidepressant effect of agomelatine and escitalopram in major depression: a retrospective investigation at a psychiatric outpatient clinic].
Topics: Acetamides; Adult; Aged; Ambulatory Care; Ambulatory Care Facilities; Antidepressive Agents; Chronobiology Phenomena; Citalopram; Depressive Disorder, Major; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2015 |
Combining threshold analysis and GRADE to assess sensitivity to bias in antidepressant treatment recommendations adjusted for depression severity.
Topics: Acetamides; Adult; Amitriptyline; Antidepressive Agents; Bayes Theorem; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Network Meta-Analysis; Paroxetine; Publication Bias; Reproducibility of Results; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
Psychological Impact of the COVID-19 Pandemic Among the Elderly: A Case Series From India.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents; Betacoronavirus; Citalopram; Clonazepam; Coronavirus Infections; COVID-19; Depressive Disorder; Female; Humans; India; Lorazepam; Male; Mirtazapine; Pandemics; Panic Disorder; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Suspected Agomelatine-induced restless legs syndrome: a case report.
Topics: Acetamides; Adult; Citalopram; Depressive Disorder, Major; Humans; Male; Restless Legs Syndrome | 2021 |